DOMAIN THERAPEUTICS ANNOUNCES FIRST PATIENT DOSED WITH DT-9081 IN PHASE I CLINICAL STUDY

20222023

Jan 7

Written By Guest User

Guest User

AMOLYT PHARMA ANNOUNCES $138 MILLION SERIES C FINANCING LED BY SOFINNOVA PARTNERS AND CO-LED BY INTERMEDIATE CAPITAL GROUP

EPITOPEA ANNONCE UN FINANCEMENT DE 14 MILLIONS DE DOLLARS